PLIANT THERAPEUTICS INC (PLRX) Institutional Shareholders

PLIANT THERAPEUTICS INC (PLRX) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $54.87M in PLRX holdings during the latest filing period.

Tang Capital Management Llc is currently the largest disclosed institutional shareholder of PLRX tracked by InsiderSet, reporting ownership valued at approximately $7.00M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $6.82M, representing an estimated loss of -2.63% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 59% of the total disclosed PLRX value among the investors covered in this analysis. Major shareholders include Tang Capital Management Llc, Adar1 Capital Management, Llc, Vanguard Capital Management Llc, and several other long-term asset managers with concentrated positions in PLIANT THERAPEUTICS INC (PLRX).

This page ranks the largest institutional PLRX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

85

Total Reported Value

$54.87M

Largest Holder

Tang Capital Management Llc

Largest Position

$7.00M

Insider Transactions (90d)

0

Latest Filing Quarter

Q2 2026

New Institutional Positions

117

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Tang Capital Management Llc0.32%6,141,261$7,001,038$6,816,800-$184,238-2.63%
Adar1 Capital Management, Llc0.30%5,509,724$6,281,085$6,115,794-$165,291-2.63%
Vanguard Capital Management Llc0.00%2,440,351$2,782,000$2,708,790-$73,210-2.63%
Acadian Asset Management Llc0.00%2,416,508$2,747,000$2,682,324-$64,676-2.35%
Two Sigma Investments, Lp0.00%2,262,832$2,579,628$2,511,744-$67,884-2.63%
Citadel Advisors Llc0.00%2,142,226$2,442,138$2,377,871-$64,267-2.63%
Renaissance Technologies LLCJim Simons0.00%2,049,874$2,336,856$2,275,360-$61,496-2.63%
Monaco Asset Management Sam0.82%1,938,747$2,210,172$2,152,009-$58,163-2.63%
Lynx1 Capital Management Lp0.24%1,798,070$2,049,800$1,995,858-$53,942-2.63%
Bml Capital Management, Llc1.01%1,546,137$1,762,596$1,716,212-$46,384-2.63%
Prosight Management, Lp0.27%1,370,233$1,562,066$1,520,959-$41,107-2.63%
Peapod Lane Capital Llc1.01%1,309,013$1,492,275$1,453,004-$39,271-2.63%
Woodline Partners Lp0.00%1,296,534$1,478,049$1,439,153-$38,896-2.63%
Blackrock, Inc.0.00%1,151,214$1,312,384$1,277,848-$34,536-2.63%
Ikarian Capital, Llc0.19%1,000,000$1,140,000$1,110,000-$30,000-2.63%
Eversept Partners, Lp0.06%891,425$1,016,224$989,482-$26,742-2.63%
Marshall Wace, Llp0.00%835,124$952,041$926,988-$25,053-2.63%
Redmile Group, Llc0.06%772,126$880,224$857,060-$23,164-2.63%
Jpmorgan Chase & Co0.00%681,647$783,894$756,628-$27,266-3.48%
Jacobs Levy Equity Management, Inc0.00%643,120$733,157$713,863-$19,294-2.63%
Geode Capital Management, Llc0.00%578,577$659,954$642,220-$17,734-2.69%
Ubs Group Ag0.00%571,760$651,806$634,654-$17,152-2.63%
Millennium Management Llc0.00%559,447$637,770$620,986-$16,784-2.63%
Bridgeway Capital Management, Llc0.01%553,630$631,138$614,529-$16,609-2.63%
Connor, Clark & Lunn Investment Management Ltd.0.00%536,081$611,132$595,050-$16,082-2.63%
Bessemer Group Inc0.00%532,079$606,000$590,608-$15,392-2.54%
Dafna Capital Management Llc0.11%487,000$555,180$540,570-$14,610-2.63%
Xtx Topco Ltd0.01%440,844$502,562$489,337-$13,225-2.63%
Laurion Capital Management Lp0.03%412,796$470,587$458,204-$12,383-2.63%
Torno Capital, Llc0.19%350,000$441,000$388,500-$52,500-11.90%
Vanguard Fiduciary Trust Co0.00%341,751$389,596$379,344-$10,252-2.63%
Boothbay Fund Management, Llc0.01%303,000$345,420$336,330-$9,090-2.63%
Morgan Stanley0.00%298,976$340,833$331,863-$8,970-2.63%
Sei Investments Co0.00%297,291$338,909$329,993-$8,916-2.63%
Verdad Advisers, Lp0.31%281,343$320,731$312,291-$8,440-2.63%
Arrowmark Colorado Holdings Llc0.01%281,189$320,555$312,120-$8,435-2.63%
Nano Cap New Millennium Growth Fund L P0.24%275,000$313,500$305,250-$8,250-2.63%
State Street Corp0.00%253,418$288,897$281,294-$7,603-2.63%
Stonepine Capital Management, Llc0.20%230,538$262,813$255,897-$6,916-2.63%
Rangeley Capital, Llc0.24%225,000$256,500$249,750-$6,750-2.63%
Goldman Sachs Group Inc0.00%208,585$237,787$231,529-$6,258-2.63%
Marquette Asset Management, Llc0.03%174,500$198,930$193,695-$5,235-2.63%
Highmark Wealth Management Llc0.06%166,224$189,495$184,509-$4,986-2.63%
Gsa Capital Partners Llp0.01%162,206$185,000$180,049-$4,951-2.68%
Vanguard Portfolio Management Llc0.00%153,712$175,232$170,620-$4,612-2.63%
Jane Street Group, Llc0.00%129,951$148,144$144,246-$3,898-2.63%
Northern Trust Corp0.00%125,060$142,568$138,817-$3,751-2.63%
Algert Global Llc0.00%123,402$140,678$136,976-$3,702-2.63%
Osaic Holdings, Inc.0.00%114,924$131,013$127,566-$3,447-2.63%
Invesco Ltd.0.00%104,678$119,333$116,193-$3,140-2.63%
Showing 50 of 85

Frequently asked questions about PLRX

  • Who owns the most PLRX stock?

    The largest holders of PLRX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for PLIANT THERAPEUTICS INC (PLRX).

  • Is PLRX widely held by superinvestors?

    Many widely followed stocks like PLRX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly PLRX is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.